These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3351842)

  • 21. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
    Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
    J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
    Wong KL; Liu HW; Ho K; Chan K; Wong R
    J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
    Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
    J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus.
    Molina JF; Gutierrez-Ureña S; Molina J; Uribe O; Richards S; De Ceulaer C; Garcia C; Wilson WA; Gharavi AE; Espinoza LR
    J Rheumatol; 1997 Feb; 24(2):291-6. PubMed ID: 9034985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies.
    Asherson RA; Lubbe WF
    J Rheumatol; 1988 Apr; 15(4):539-43. PubMed ID: 3294408
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiphospholipid antibody syndrome: immunologic and clinical aspects.
    Sammaritano LR; Gharavi AE; Lockshin MD
    Semin Arthritis Rheum; 1990 Oct; 20(2):81-96. PubMed ID: 2251509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival in systemic lupus erythematosus.
    Ridley MG; Long PJ; Hughes GR
    Br J Hosp Med; 1988 Mar; 39(3):237-41. PubMed ID: 3282590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiphospholipid antibodies: which ones and when?].
    Cervera R; Font J
    Rev Clin Esp; 1989 Oct; 185(6):279-81. PubMed ID: 2695993
    [No Abstract]   [Full Text] [Related]  

  • 30. Pathogenesis of systemic lupus erythematosus. Possible participation of antiphospholipid antibodies.
    Alarcón-Segovia D
    Isr J Med Sci; 1989 Dec; 25(12):669-74. PubMed ID: 2693397
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiphospholipid antibodies and ischemic cerebrovascular disease.
    Levine SR; Brey RL
    Semin Neurol; 1991 Dec; 11(4):329-38. PubMed ID: 1811290
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus.
    Weidmann CE; Wallace DJ; Peter JB; Knight PJ; Bear MB; Klinenberg JR
    J Rheumatol; 1988 Jan; 15(1):74-9. PubMed ID: 3351842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antiphospholipid antibodies: new data in the pathogenesis of collagenosis].
    Grob JJ; Bonerandi JJ
    Ann Dermatol Venereol; 1986; 113(9):811-8. PubMed ID: 3548543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The antiphospholipid syndrome: clinical and immunological aspects].
    Nasonov EL
    Klin Med (Mosk); 1989 Jan; 67(1):5-13. PubMed ID: 2654465
    [No Abstract]   [Full Text] [Related]  

  • 35. Repeated intestinal ulcerations in a patient with systemic lupus erythematosus and high serum antiphospholipid antibody levels.
    Sasamura H; Nakamoto H; Ryuzaki M; Kumagai K; Abe S; Suzuki H; Hirakata M; Tojo T; Handa M; Yamamoto M
    South Med J; 1991 Apr; 84(4):515-7. PubMed ID: 2014444
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.